A facilitated access program to provide Everolimus (RAD) for maintenance for patients completing therapy in RAD trials in solid organ transplantation.
- Registry ID
- EUCTR2004-001473-25
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Novartis Pharmaceuticals Corporation
- Start date
- 2005-01-27
- Completion date
- 2014-02-14
- Last update
- 2026-08-16
Conditions
- Solid Organ Transplant - maintenace phase
- Solid organ transplantation
Summary
To facilitate the management of patients on maintenance immunosuppression therapy who are completing everolimus trials. To provide everolimus maintenance therapy through this access program and to collect and review safety data until drug is commercially available or the project has been discontinued.
Locations
View on source registry